Cart
sales@molnova.com
Hydroxypropyl Cellulose
CAS No. 9004-64-2
Hydroxypropyl Cellulose( Hyprolose | HPC-L | L-Hpc | Hyprolosum | Oxypropylated cellulose )
Catalog No. M19243 CAS No. 9004-64-2
Hydroxypropyl cellulose (HPC) is a derivative of cellulose with both water solubility and organic solubility, it is used as food additive and sieving matrix for DNA separations.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 49 | In Stock |
|
| 50MG | 72 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHydroxypropyl Cellulose
-
NoteResearch use only, not for human use.
-
Brief DescriptionHydroxypropyl cellulose (HPC) is a derivative of cellulose with both water solubility and organic solubility, it is used as food additive and sieving matrix for DNA separations.
-
DescriptionHyprolose is a derivative of cellulose with both water solubility and organic solubility. It is used as an excipient, and topical ophthalmic protectant and lubricant.
-
In Vitro——
-
In Vivo——
-
SynonymsHyprolose | HPC-L | L-Hpc | Hyprolosum | Oxypropylated cellulose
-
PathwayTyrosine Kinase
-
TargetBcr-Abl
-
RecptorOthers
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number9004-64-2
-
Formula Weight59.09
-
Molecular FormulaC3H8O2·xUnspecified
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCC(C1=C(C=C(C=C1)N(C)C)C)N
-
Chemical NameCellulose, 2-hydroxypropyl ether
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Sanders JC, et al. Anal Chem, 2003, 75(4), 986-994.
molnova catalog
related products
-
Docetaxel trihydrate
Docetaxel trihydrate(Taxotere trihydrate), an analog of taxol, is an inhibitor of depolymerisation of microtubules through binding to stabilized microtubules.
-
TIC10 isomer
TIC10 inactivates Akt and ERK to induce TRAIL through Foxo3a, possesses superior drug properties: delivery across the blood-brain barrier, superior stability and improved pharmacokinetics. Phase 1/2.
-
GNF-5
GNF-5, an analogue of GNF-2 with improved pharmacokinetic properties, is a selective non-ATP competitive inhibitor of Bcr-Abl with an IC50 value of 0.22±0.1 uM (Wild type Abl).
